What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts during the week of July 28-August 1.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Find all top-rated stocks by the best-rated analysts on TipRanks.
Top 5 Buy Calls:
1. HSBC upgrades Meta to Buy on AI-driven growth
HSBC upgraded Meta Platforms (META) to Buy from Hold with a price target of $900, up from $610. The company reported strong Q2 results as its artificial intelligence tools and network effect supported double-digit revenue growth, the firm tells investors in a research note. HSBC believes Meta is well positioned to outpace digital advertising market growth. The company’s AI capabilities improve targeting and the quality of content, creating new growth opportunities, contends HSBC. The firm cites higher operational forecasts and a higher valuation multiple for the upgrade.
2. Microsoft upgraded to Overweight at KeyBanc
KeyBanc analyst Jackson Ader upgraded Microsoft (MSFT) to Overweight from Sector Weight with a $630 price target following the fiscal Q4 report. The firm says the fears of its downgrade in April have not played out. Azure growth accelerated eight percentage points over the second half of Microsoft’s fiscal year and there was no mention of macro headwinds on the earnings call, the analyst tells investors in a research note.
3. Nike upgraded to Overweight at JPMorgan
JPMorgan upgraded Nike (NKE) to Overweight from Neutral with a price target of $93, up from $64. The firm increased Nike’s estimates for the first time in 13 months following its fieldwork and talks with management. It sees a multi-year recovery for the company, driving high-teens to 20% annual earnings growth through fiscal 2030.
4. Peloton upgraded to Buy at UBS
UBS upgraded Peloton (PTON) to Buy from Neutral with a price target of $11, up from $7.50, which implies a near doubling of the stock from current levels. The firm sees upside to Peloton’s fiscal 2026 EBITDA expectations from sales growth and further cost cutting. The shares are trading at a favorable risk/reward and “undemanding” valuation, UBS tells investors in a research note. The firm adds that the data it tracks for Peloton has been improving.
5. Sarepta upgraded to Outperform at Oppenheimer
Oppenheimer analyst Andreas Argyrides upgraded Sarepta (SRPT) to Outperform from Perform with a price target of $37, up from $30, after the FDA recommended to remove the voluntary hold of Elevidys for ambulatory patients. The firm believes the news is the desired outcome for the Duchenne muscular dystrophy community and provides additional comfort that the gene therapy’s risk-benefit profile remains favorable in ambulatory patients. Opco cites the removal of the regulatory overhang and Elevidys being back on the market for the upgrade.
Top 5 Sell Calls:
1. UnitedHealth downgraded to Underperform at Baird
Baird downgraded UnitedHealth (UNH) to Underperform from Neutral with a price target of $198, down from $312. The firm sees a more challenging road ahead for UnitedHealth following the Q2 report. It has low conviction on the company’s ability to maintain 1% OptumHealth value-based care margins in 2026 and believes UnitedHealth’s other segments now appear more challenged than anticipated. Even in an optimistic scenario for earnings growth, the stock’s current price “does not appear overly inexpensive,” Baird tells investors in a research note.
2. Paramount downgraded to Sell at Seaport on strategy questions post deal close
Seaport Research downgraded Paramount (PARA, PARAA, PSKY) to Sell from Neutral with an $11 price target on B shares, which the firm notes will trade under the ticker symbol “PSKY” after August 7 following the closing of the Skydance merger. Ahead of the merger closing, the firm is reducing its “too-robust” advertising and filmed entertainment estimates for Q3 and beyond, noting that it still sees upside in the short-term, but sees risk that shares could give back some of the deal-related upside post-tender. The firm also sees questions surrounding the go-forward strategy post-close and tender, adds Seaport, which has a $17 price target on Paramount A shares, whose holders will receive cash or 1.533 PSKY shares upon deal closing.
3. Accenture initiated with a Reduce at HSBC
HSBC initiated coverage of Accenture (ACN) with a Reduce rating and $240 price target. The firm believes the market is underestimating the artificial intelligence disruption risk facing Accenture. Early successful generative artificial intelligence use cases are likely to significantly boost employee productivity in Accenture’s core offerings, which will likely translate into pricing pressure over time, HSBC tells investors in a research note.
4. KeyBanc downgrades Albemarle on recent rally in shares
KeyBanc downgraded Albemarle (ALB) to Sector Weight from Overweight without a price target. The firm cites the recent share outperformance for the downgrade. In addition, current lithium prices are below reinvestment levels, which is unsustainable over the long term, KeyBanc tells investors in a research note. The firm views the stock’s 24% rally since June 23 as an “opportunity to reduce risk.” It does not see the momentum driving a new lithium price cycle over the next 6-12 months.
5. Goldman downgrades Avis Budget to Sell on “stretched” valuation
Goldman Sachs downgraded Avis Budget (CAR) to Sell from Neutral with a price target of $105, up from $87. The firm views the stock’s valuation as “stretched” following doubling over the past three months. Goldman says that with no big inflection in revenue per day during Q2 as well as higher cost investments and supply issues, it continues to estimate $1.1B of normalized EBITDA for Avis. It sees a lack of catalysts for the company’s EBITDA inflecting higher and downside risk to consensus estimates.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on META:
- Snap Is About to Report Q2 Earnings. Here’s What to Expect
- Top 3 Trending Stocks, According to Analysts – 8/1/2025
- Private Markets: Scale rival Surge AI in talks for funding at $25B value
- Meta Is Now Targeting Startups that Specialize in AI Videos
- Meta Platforms Receives Buy Rating from Saiyi He Amid Strong Financial Performance and Strategic AI Advancements